CWP
LLY icon

Concord Wealth Partners’s Eli Lilly LLY Stock Holding History

Concord Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41M Buy
3,673
+308
+9% +$315K 0.5% 46
2026
Q1 		$3.1M Sell
3,365
-280
-8% -$284K 0.4% 63
2025
Q4 		$3.92M Buy
3,645
+118
+3% +$113K 0.51% 42
2025
Q3 		$2.69M Sell
3,527
-125
-3% -$93K 0.37% 63
2025
Q2 		$2.85M Sell
3,652
-151
-4% -$117K 0.42% 54
2025
Q1 		$3.14M Sell
3,803
-1,610
-30% -$1.34M 0.52% 49
2024
Q4 		$4.18M Buy
5,413
+346
+7% +$286K 0.68% 34
2024
Q3 		$4.49M Buy
5,067
+416
+9% +$374K 0.75% 37
2024
Q2 		$4.21M Buy
4,651
+20
+0.4% +$16K 0.74% 35
2024
Q1 		$3.6M Buy
4,631
+987
+27% +$702K 0.65% 39
2023
Q4 		$2.12M Buy
3,644
+615
+20% +$359K 0.43% 52
2023
Q3 		$1.63M Sell
3,029
-400
-12% -$206K 0.35% 51
2023
Q2 		$1.61M Buy
3,429
+981
+40% +$411K 0.35% 49
2023
Q1 		$841K Buy
2,448
+361
+17% +$122K 0.24% 58
2022
Q4 		$764K Sell
2,087
-857
-29% -$304K 0.23% 61
2022
Q3 		$952K Buy
2,944
+41
+1% +$13K 0.3% 48
2022
Q2 		$941K Buy
2,903
+772
+36% +$232K 0.26% 54
2022
Q1 		$610K Sell
2,131
-22
-1% -$5.66K 0.16% 86
2021
Q4 		$595K Buy
2,153
+844
+64% +$214K 0.15% 87
2021
Q3 		$302K Sell
1,309
-1,102
-46% -$272K 0.12% 60
2021
Q2 		$553K Buy
2,411
+678
+39% +$136K 0.16% 61
2021
Q1 		$324K Buy
1,733
+1,062
+158% +$208K 0.11% 91
2020
Q4 		$113K Buy
+671
New +$100K 0.09% 122

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Concord Wealth Partners's LLY Position: Q2 2026 in Review

Concord Wealth Partners increased its Eli Lilly (LLY) stake by 9.2% in Q2 2026, buying an estimated $315K and bringing the position to 3,673 shares worth $4.41M. The position accounts for 0.5% of the portfolio, ranked #46.

Concord Wealth Partners first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.49M in Q3 2024. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Concord Wealth Partners held 3,673 shares of Eli Lilly worth $4.41M as of Q2 2026.
  • Concord Wealth Partners bought 308 Eli Lilly shares in Q2 2026, an estimated $315K.
  • Eli Lilly made up 0.5% of Concord Wealth Partners's portfolio in Q2 2026, its #46 holding.
  • Concord Wealth Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • Concord Wealth Partners's Eli Lilly position peaked at $4.49M in Q3 2024.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.